Insulin analogs and new oral antidiabetic drugs
Koivisto, V.
Duodecim; Laaketieteellinen Aikakauskirja 115(20): 2197-2202
1999
ISSN/ISBN: 0012-7183 PMID: 11973922 Document Number: 509240
Document emailed within 1 workday
Related Documents
Panicker, G.K.; Karnad, D.R.; Salvi, V.; Kothari, S. 2012: Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs Journal of the Association of Physicians of India 60: 56-61Auzepy, P.; Caquet, R. 1983: Severe hypoglycemia due to insulin. Risks and adverse effects of antidiabetic drugs La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(10): 697-705
Francia, E.; Marin, A.; Verdejo, F.; Sanchez, M.S.; Morell, J. 1975: New oral antidiabetic drugs. Synthesis and structure-activity relationships Bollettino Chimico Farmaceutico 114(7): 379-392
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Fabbian, F.; De Giorgi, A.; Monesi, M.; Tiseo, R.; Storari, A.; Mallozzi Menegatti, A.; Pala, M.; Tomasi, F.; Portaluppi, F.; Manfredini, R. 2014: Prescription of oral antidiabetic drugs in K/DIGO chronic kidney disease stage 3 and 4: a single centre report Minerva Urologica e Nefrologica 66(1): 69-75
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Panikar, V.; Joshi, S.R.; Deogaonkar, N.; Vadgama, J.; Nasikkar, N.; Kamat, T.; Sheikh, S.; Jain, C.C.; Wagle, T. 2018: Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic Drugs Journal of the Association of Physicians of India 66(12): 46-49
Patel, R.B.; Shah, G.F.; Raval, J.D.; Patel, M.R. 1987: Influence of antidiabetic drugs on the activity of nonsteroidal anti-inflammatory drugs in carrageenan paw edema test in the rat Indian Journal of Physiology and Pharmacology 31(4): 289-292
Jungmann, E. 1997: From human insulin to designer insulin. Why insulin analogs? Fortschritte der Medizin 115(12): 40-41
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Johansen, K. 2001: New oral antidiabetic glitazones Ugeskrift for Laeger 164(1): 76-77
Hepp, K.D. 1983: Fenfluramine as an oral antidiabetic Münchener Medizinische Wochenschrift 125(46): 126-127
Stanulović, M.; Jakovljević, V.; Kovac, T.; Lepsanović, L.; Ducić, M. 1986: Regional and international comparison in utilization of antidiabetic drugs International Journal of Clinical Pharmacology Therapy and Toxicology 24(5): 254-256
Schroner, Z.; Javorsky, M.; Kozarova, M.; Tkac, I. 2011: Pharmacogenetics of oral antidiabetic treatment Bratislavske Lekarske Listy 112(8): 441-446
Haslbeck, M. 1979: New aspects of therapy with oral antidiabetic agents Wiener Medizinische Wochenschrift 199(24): 689-695
Schumm-Draeger, P-Maria. 2006: Current treatment with oral antidiabetic agents MMW Fortschritte der Medizin 148(9): 33-35
Nelson, S.A.; Wilson, G.A.; Tucci, M.; Benghuzzi, H. 2015: The Effect of Selective Serotonin Reuptake Inhibitors and Antidiabetic Drugs on Cardiomyocytes Biomedical Sciences Instrumentation 51: 400-406
Vázquez, M.; Silvestre, J.S.; Prous, J.R. 2002: Experimental approaches to study PPAR gamma agonists as antidiabetic drugs Methods and Findings in Experimental and Clinical Pharmacology 24(8): 515-523
Blumenbach, L.; Gerhards, E.; Gutsche, H.; Klein, W.; Loge, O.; Losert, W.; Schillinger, E.; Speck, U.; Vetter, H.; Wendt, H. 1975: Gliflumide, a new oral antidiabetic of high potency and efficacy International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 141-151